Learning Center
Webinars
-
Contains 3 Component(s), Includes Credits Includes a Live Web Event on 09/23/2026 at 1:00 PM (EDT)
Selecting the appropriate infusion flow-control device requires an understanding of infusion pump technology capabilities and the needs of the clinical systems in which they are used for infusion therapy. This session provides a foundational overview of factors that influence flow-control device selection, key infusion pump safety features, and the role of smart pumps and dose-error reduction systems (DERS) in supporting medication safety. Participants will explore device technology differences, drug library configuration, dead volume, management of fluid container overfill, how administration set and accessory design can contribute to medication errors, and clinical sources and implications for dosing accuracy. Through evidence-based discussion and case study examples, learners will build a systems-based understanding of how infusion technology, clinical practice and organizational safety strategies work together to promote safe, accurate, and effective infusion therapy.
Selecting the appropriate infusion flow-control device requires an understanding of infusion pump technology capabilities and the needs of the clinical systems in which they are used for infusion therapy. This session provides a foundational overview of factors that influence flow-control device selection, key infusion pump safety features, and the role of smart pumps and dose-error reduction systems (DERS) in supporting medication safety.
Participants will explore device technology differences, drug library configuration, dead volume, management of fluid container overfill, how administration set and accessory design can contribute to medication errors, and clinical sources and implications for dosing accuracy. Through evidence-based discussion and case study examples, learners will build a systems-based understanding of how infusion technology, clinical practice and organizational safety strategies work together to promote safe, accurate, and effective infusion therapy.
Learning Objectives: At the conclusion of this session, learners will be able to:
- Explain factors used to select the appropriate flow-control device for infusion therapy
- Identify essential infusion pump safety features that support safe medication delivery
- Describe the role of smart pumps for reducing infusion-related medication errors and adverse drug events
- Evaluate flow rate accuracy, dead volume and fluid container overfill and explore their implications on medication and fluid delivery
- Identify how administration-set design and accessory devices contribute to dead volume and influence medication delivery
Jeannine Blake, PhD, RN
Assistant Professor
University of Massachusetts Amherst
Jeannine Blake, PhD, RN, is a nurse scientist with a clinical background in surgical intensive care nursing and a passion for advancing health care innovation using an interdisciplinary nurse-engineer approach. Her research focuses on improving intravenous (IV) pumping technology accuracy, flow steadiness, usability, and reducing alarm burden on nurses and patients. She is dedicated to improving patient outcomes, streamlining nursing workflows, and integrating IV pumps more effectively into real-world clinical practices.
Dr Blake earned her PhD in Nursing Science and completed a Postdoctoral Research Fellowship in Engineering at the University of Massachusetts Amherst. She is now an Assistant Professor in the Elaine Marieb College of Nursing and is affiliated with the Elaine Marieb Center for Nursing and Engineering Innovation.
Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN
Clinical Nurse Specialist
The James Cancer Hospital at The Ohio State Wexner Medical Center
Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN, is a Clinical Nurse Specialist at The Ohio State University Wexner Medical Center, where her work focuses on advancing safe, evidence-based infusion therapy practices. Her clinical and scholarly interests include intravenous smart pump technology, medication delivery, infusion system design, and the ways nurses interact with infusion devices in complex care environments. Ms Meade has presented nationally on considerations and limitations associated with intravenous smart pump medication administration and the implications of infusion technology for patient safety. Karen is also a doctoral student at the University of Massachusetts Amherst, where her research examines the use of intravenous smart pump-generated data to better understand alarm phenomena, nurse-pump interactions, and opportunities to improve the safety and effectiveness of infusion therapy.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: September 23, 2029
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
As artificial intelligence (AI) continues to transform health care delivery, clinicians must first understand the fundamentals before safely applying these technologies in practice. This session will provide a practical introduction to artificial intelligence, machine learning, generative AI, and emerging technologies shaping the future of patient care.
As artificial intelligence (AI) continues to transform health care delivery, clinicians must first understand the fundamentals before safely applying these technologies in practice. This session will provide a practical introduction to artificial intelligence, machine learning, generative AI, and emerging technologies shaping the future of patient care.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe the data pathway from point of entry to storage to extraction for measuring patient outcomes
• Explain the process of building on data to artificial intelligence
• Discuss the applications that are the result of the process of data to artificial intelligence
• Discuss introduction to artificial intelligence in health care and nursingJane Carrington, PhD, RN, FAMIA, FAAN
Jane Carrington, PhD, RN, FAMIA, FAAN, has over 26 years of experience as an analyst, scientist, and educator. She has worked to advance technology and artificial intelligence (AI) in nursing. Her emphasis is the electronic health record as a communication system and data guiding health care decision-making. She has emerged as a leader in nursing-education, health care, and artificial intelligence. Dr Carrington has been working to assist nursing programs to achieve success in faculty understanding AI, it's application in nursing education, and preparation of nursing students for the challenges in working with advancing technology.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: August 19, 2029
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits
Medication administration errors (MAEs) remain a leading cause of preventable patient harm and are a significant concern in outpatient infusion settings where nurses often assume primary responsibility for medication preparation, verification, administration, and patient education. As infusion services continue to expand, organizations need practical and sustainable strategies to strengthen medication safety and reduce the risk of errors associated with high-risk intravenous therapies. This comprehensive practice-focused session will examine common system and human factors contributing to MAEs, review the implementation of a structured Medication Administration Evaluation and Feedback Tool (MAEFT), and present outcomes from a multi-site outpatient infusion quality improvement initiative. Participants will gain practical approaches for applying observation, feedback, and procedural safety practices to improve adherence to medication administration standards and support a culture of safety. In this session, we will explore medication safety risks in outpatient infusion practice, discuss implementation of the MAEFT framework, and identify strategies that infusion nurses can use to improve medication administration safety and patient outcomes.
Medication administration errors (MAEs) remain a leading cause of preventable patient harm and are a significant concern in outpatient infusion settings where nurses often assume primary responsibility for medication preparation, verification, administration, and patient education. As infusion services continue to expand, organizations need practical and sustainable strategies to strengthen medication safety and reduce the risk of errors associated with high-risk intravenous therapies. This comprehensive practice-focused session will examine common system and human factors contributing to MAEs, review the implementation of a structured Medication Administration Evaluation and Feedback Tool (MAEFT), and present outcomes from a multi-site outpatient infusion quality improvement initiative. Participants will gain practical approaches for applying observation, feedback, and procedural safety practices to improve adherence to medication administration standards and support a culture of safety. In this session, we will explore medication safety risks in outpatient infusion practice, discuss implementation of the MAEFT framework, and identify strategies that infusion nurses can use to improve medication administration safety and patient outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
1. Describe common system and human factors contributing to medication administration errors in outpatient infusion settings
2. Explain how structured observation and feedback strategies can be used to improve medication administration safety and clinician adherence to best practices
3. Discuss the implementation and application of the Medication Administration Evaluation and Feedback Tool (MAEFT) to strengthen medication safety practices in outpatient infusion clinicsValerie Brady, DNP, MSN-Ed, APRN, FNP-C
Valerie Brady, DNP, MSN-Ed, APRN, FNP-C, is a Family Nurse Practitioner, nurse educator, and health care leader with more than 25 years of nursing experience spanning pediatrics, oncology, emergency care, labor and delivery, infusion therapy, and nursing education. She currently serves as an Instructor Faculty Associate at Arizona State University and has held leadership roles in outpatient infusion practice, including serving as Clinical Education Manager and Family Nurse Practitioner for a multi-state infusion organization, where she provided clinical oversight, onboarding, competency development, and continuing education for more than 200 clinicians across 6 states. In addition to her academic and clinical practice roles, Dr Brady currently consults with an outpatient infusion organization on clinical operations, education, and quality improvement initiatives. She recently completed her Doctor of Nursing Practice degree at Northern Arizona University, focusing on medication safety in outpatient infusion clinics. Dr Brady’s combined clinical, leadership, consulting, and academic experience provides a unique perspective on advancing medication safety and quality improvement in infusion nursing practice.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: July 29, 2029
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits
Hereditary Hemochromatosis (HH), a genetic condition characterized by excessive iron accumulation, is prevalent among Northern European populations, causes excessive iron accumulation, and requires regular therapeutic phlebotomy (blood removal) for treatment. Despite critical global blood shortages, this blood is often discarded based on outdated safety concerns. A rapid review of literature was conducted to assess the safety and effectiveness of using blood from uncomplicated HH patients. The review found strong evidence that blood from HH donors is safe, effective, and comparable to that of healthy donors. Specifically, red blood cells from HH donors improve hemoglobin increments in transfusion recipients, and their platelet quality is comparable to healthy donors. This evidence strongly supports updating policies to integrate HH patients into the general blood supply and mitigate the professional liability associated with the unnecessary waste of a valuable medical resource.
Hereditary Hemochromatosis (HH), a genetic condition characterized by excessive iron accumulation, is prevalent among Northern European populations, causes excessive iron accumulation, and requires regular therapeutic phlebotomy (blood removal) for treatment. Despite critical global blood shortages, this blood is often discarded based on outdated safety concerns. A rapid review of literature was conducted to assess the safety and effectiveness of using blood from uncomplicated HH patients. The review found strong evidence that blood from HH donors is safe, effective, and comparable to that of healthy donors. Specifically, red blood cells from HH donors improve hemoglobin increments in transfusion recipients, and their platelet quality is comparable to healthy donors. This evidence strongly supports updating policies to integrate HH patients into the general blood supply and mitigate the professional liability associated with the unnecessary waste of a valuable medical resource.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Explain the clinical necessity of therapeutic phlebotomy for hemochromatosis patients and the global blood supply implications of discarding this blood.
• Analyze the safety and efficacy data of blood collected from uncomplicated HH patients, as evidenced by a rapid review of the literature.
• Compare the quality of key blood components (red cells and platelets) from HH donors against those from healthy donors.
• Justify policy changes and propose strategies to safely integrate uncomplicated HH patients into standard blood donation programs.Fatima Karashi, MSN, BSN, RN
Fatima Karashi, MSN, BSN, RN, has a master’s degree in Nursing Leadership and Management, with experience in ambulatory and specialty care, nursing leadership, quality improvement, and evidence-based practice. Throughout her career, she has been actively involved in initiatives aimed at enhancing patient care, improving health care processes, and supporting professional development within multidisciplinary teams. Ms Karashi’s academic background and professional experience have strengthened her interest in research and the application of evidence to practice. This presentation reflects her commitment to advancing health care through evidence-informed decision-making. By synthesizing and evaluating current literature, this work seeks to provide meaningful insights that can inform clinical practice, health care policy, and future research.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: June 30, 2029
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits Recorded On: 05/27/2026
Peripheral intravenous catheter (PIVC) insertion is a routine procedure in emergency departments (EDs), yet current practice often deviates from evidence-based standards. Research highlights key issues, including unnecessary (idle) catheter insertion, overuse of antecubital fossa (ACF) sites, and limited patient involvement in decision-making. These gaps can lead to avoidable patient harm, reduced comfort, and inefficient use of resources. This intermediate-level session will provide an evidence-informed overview of these challenges and the factors driving them. In this session, we will examine the evidence–practice gap in ED PIVC care and identify practical, patient-centered strategies to improve clinical decision-making and outcomes.
Peripheral intravenous catheter (PIVC) insertion is a routine procedure in emergency departments (EDs), yet current practice often deviates from evidence-based standards. Research highlights key issues, including unnecessary (idle) catheter insertion, overuse of antecubital fossa (ACF) sites, and limited patient involvement in decision-making. These gaps can lead to avoidable patient harm, reduced comfort, and inefficient use of resources. This intermediate-level session will provide an evidence-informed overview of these challenges and the factors driving them. In this session, we will examine the evidence–practice gap in ED PIVC care and identify practical, patient-centered strategies to improve clinical decision-making and outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Analyze the current gaps between evidence-based guidelines and real-world PIVC practices in emergency departments
• Evaluate the clinical, behavioral, and system-level factors contributing to suboptimal practices, including ACF insertion and idle catheter use
• Apply evidence-based and patient-centered strategies to improve PIVC decision-making, insertion, and care in the ED settingGrace Xu, Phd, RN
Dr Grace (Hui) Xu, PhD, is a Nurse Practitioner at an Emergency Trauma Center in Australia and a Senior Implementation Science Research Fellow at the Queensland University of Technology. As a Clinician-Researcher, Dr Xu is dedicated to the core belief that patients in emergency departments should receive medical treatment without any associated harm.
Her work focuses on advocating and promoting evidence-based practices in patient care, with a particular emphasis on optimizing insertions and preventing complications associated with vascular access devices in emergency settings.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: May 27, 2029
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register